102 related articles for article (PubMed ID: 20355348)
1. Less-than-standard treatment in rectal cancer patients: which patients are at risk?
Pisu M; Richardson LC; Kim YI; Krontiras H; Martin MY; Salas M; Pollack LA
J Natl Med Assoc; 2010 Mar; 102(3):190-8. PubMed ID: 20355348
[TBL] [Abstract][Full Text] [Related]
2. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.
Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M
Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928
[TBL] [Abstract][Full Text] [Related]
3. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population.
Dobie SA; Warren JL; Matthews B; Schwartz D; Baldwin LM; Billingsley K
Cancer; 2008 Feb; 112(4):789-99. PubMed ID: 18189291
[TBL] [Abstract][Full Text] [Related]
4. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada.
Eldin NS; Yasui Y; Scarfe A; Winget M
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914
[TBL] [Abstract][Full Text] [Related]
5. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer.
Cheung WY; Neville BA; Earle CC
Dis Colon Rectum; 2009 Jun; 52(6):1054-63; discussion 1064. PubMed ID: 19581846
[TBL] [Abstract][Full Text] [Related]
6. Use of surgical procedures and adjuvant therapy in rectal cancer treatment: a population-based study.
Schroen AT; Cress RD
Ann Surg; 2001 Nov; 234(5):641-51. PubMed ID: 11685027
[TBL] [Abstract][Full Text] [Related]
7. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study.
Neugut AI; Fleischauer AT; Sundararajan V; Mitra N; Heitjan DF; Jacobson JS; Grann VR
J Clin Oncol; 2002 Jun; 20(11):2643-50. PubMed ID: 12039925
[TBL] [Abstract][Full Text] [Related]
8. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare.
Schrag D; Gelfand SE; Bach PB; Guillem J; Minsky BD; Begg CB
J Clin Oncol; 2001 Sep; 19(17):3712-8. PubMed ID: 11533092
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
Sun Z; Gilmore B; Adam MA; Kim J; Hsu SD; Migaly J; Mantyh CR
Dis Colon Rectum; 2017 Oct; 60(10):1050-1056. PubMed ID: 28891848
[TBL] [Abstract][Full Text] [Related]
10. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
11. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
Fang P; He W; Gomez DR; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):748-757. PubMed ID: 28366580
[TBL] [Abstract][Full Text] [Related]
12. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ
Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162
[TBL] [Abstract][Full Text] [Related]
13. [Practical neoadjuvant and adjuvant therapies for rectal cancer. How many patients are actually recruited in multimodality therapy concepts? An analysis of the Tumour Centre Schwerin].
Sauer J; Sobolewski K; Dommisch K
Zentralbl Chir; 2009 Sep; 134(5):450-4. PubMed ID: 19757345
[TBL] [Abstract][Full Text] [Related]
14. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.
Ayanian JZ; Zaslavsky AM; Fuchs CS; Guadagnoli E; Creech CM; Cress RD; O'Connor LC; West DW; Allen ME; Wolf RE; Wright WE
J Clin Oncol; 2003 Apr; 21(7):1293-300. PubMed ID: 12663717
[TBL] [Abstract][Full Text] [Related]
15. Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer.
van Erning FN; Rutten HJ; van den Berg HA; Lemmens VE; van Halteren HK
Eur J Surg Oncol; 2015 Dec; 41(12):1630-5. PubMed ID: 26437853
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant radiation above NCCN guidelines for rectal cancer is associated with age under 50 and early clinical stage.
Bliggenstorfer JT; Bingmer K; Ofshteyn A; Stein SL; Charles R; Steinhagen E
Surg Endosc; 2022 May; 36(5):2925-2935. PubMed ID: 34114070
[TBL] [Abstract][Full Text] [Related]
17. Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration.
Landrum MB; Keating NL; Lamont EB; Bozeman SR; McNeil BJ
Cancer; 2012 Jul; 118(13):3345-55. PubMed ID: 22072536
[TBL] [Abstract][Full Text] [Related]
18. Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography.
Monson JR; Probst CP; Wexner SD; Remzi FH; Fleshman JW; Garcia-Aguilar J; Chang GJ; Dietz DW;
Ann Surg; 2014 Oct; 260(4):625-31; discussion 631-2. PubMed ID: 25203879
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision?
Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K
Am Surg; 1997 Jul; 63(7):579-84; discussion 584-5. PubMed ID: 9202530
[TBL] [Abstract][Full Text] [Related]
20. Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: a population-based analysis.
Rayson D; Urquhart R; Cox M; Grunfeld E; Porter G
J Oncol Pract; 2012 Jul; 8(4):253-9. PubMed ID: 23180992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
